YOLFTbeta
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A

Wuhan Easy Diagnosis Biomedicine Co Ltd Class A

002932 · SHE · Healthcare / Medical Devices

14.46CNY-0.02 (-0.14%)

Price History

Full chart

Market Stats

Previous Close14.48
Open14.48
Day Range14.43 – 14.52
52-Week Range13.67 – 20.87
Volume491.24K
Market Cap3.56B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.23
Dividend Yield0.00%
Beta0.36
50-Day Avg15.10
200-Day Avg16.64

About

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, production, and sale of vitro diagnostic reagents and diagnostic instruments in China. The company offers external diagnostic testing, third-party medical testing, certification consulting services, and medical information platform construction services, as well as nutrition and health products for immune, gut, reproductive, and sleep health management. It also provides information software and supporting hardware products. In addition, the company offers blood gas and chemistry analyzers, fluorescence immunoassay analyzers, molecular diagnosis kit, coagulation analysis machine, and automated glycohemoglobin detection machine. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. was founded in 2008 and is based in Wuhan, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMs. Chen Li Li
  • Employees599
  • HeadquartersEast Lake New Technology Development Zone, Wuhan, China, 430075, China
  • Websitehttps://www.mdeasydiagnosis.com

Leadership

  • Ms. Chen Li LiChairman & GM · b. 1974
  • Ms. Wang YingVice Chairman & Deputy GM · b. 1974
  • Mr. Rui WangDeputy GM, CFO & Board Secretary · b. 1978
  • Chaohui LiAccounting Supervisor

Financials

Income Statement

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.22M7.10M25.95M57.80M95.34M140.98M165.12M176.38M181.16M959.10M2.83B10.53B749.54M350.06M265.08M
Growth (%)-+482.57%+265.66%+122.77%+64.94%+47.87%+17.13%+6.82%+2.71%+429.43%+195.05%+272.12%-92.88%-53.30%-24.28%
Cost of Revenue462.84K2.92M7.63M16.89M20.36M21.37M31.20M40.85M47.22M209.97M707.41M3.99B309.72M217.75M169.21M
Gross Profit755.21K4.17M18.32M40.91M74.98M119.61M133.92M135.53M133.94M749.13M2.12B6.54B439.82M132.31M95.87M
Gross Margin62.00%58.80%70.59%70.78%78.64%84.84%81.10%76.84%73.94%78.11%75.00%62.09%58.68%37.80%36.16%
Operating Expense999.73K2.81M10.00M18.65M33.76M52.51M58.26M67.24M92.40M186.85M424.61M1.46B294.62M91.12M201.81M
Operating Income-244.52K1.36M8.31M22.27M41.22M67.09M75.66M68.30M41.54M562.28M1.70B5.08B145.19M41.19M-105.95M
Operating Margin-20.07%19.16%32.04%38.52%43.23%47.59%45.82%38.72%22.93%58.63%60.00%48.24%19.37%11.77%-39.97%
EBITDA344.20K1.74M8.96M25.74M43.10M73.43M84.99M84.39M63.43M574.59M1.72B5.12B216.80M90.96M-8.96M
EBITDA Margin28.26%24.47%34.53%44.53%45.21%52.09%51.47%47.84%35.01%59.91%60.71%48.67%28.92%25.98%-3.38%
Net Income253.24K1.40M7.32M21.54M35.60M59.69M65.49M61.42M41.53M468.93M1.41B4.21B74.93M74.52M-16.46M
Net Income Margin20.79%19.76%28.22%37.26%37.34%42.34%39.66%34.82%22.92%48.89%49.94%39.97%10.00%21.29%-6.21%
R&D--2.16M3.37M8.74M20.98M25.61M27.10M36.96M69.93M132.74M388.36M141.42M109.55M85.78M
R&D as % of Total Revenue--8.32%5.83%9.16%14.88%15.51%15.37%20.40%7.29%4.69%3.69%18.87%31.29%32.36%
Interest Expense51.00K83.36K52.77K36.61K34.67K45.10K6.44K441.76K95.90K822.63K2.67M4.31M10.50M1.49M458.65K
Interest Expense % of Total Revenue4.19%1.17%0.20%0.06%0.04%0.03%0.00%0.25%0.05%0.09%0.09%0.04%1.40%0.43%0.17%

Balance Sheet

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.96M4.66M23.79M61.01M133.96M197.15M256.54M617.15M638.42M1.43B3.42B9.19B7.39B6.59B5.98B
Total Liabilities1.94M3.23M10.19M11.42M18.57M22.07M13.60M24.55M22.80M311.77M567.02M2.42B1.09B574.40M324.56M
Total Equity21.45K1.42M13.60M49.59M115.39M175.08M240.57M588.16M609.71M1.10B2.79B6.50B6.03B5.83B5.53B
Cash628.69K994.92K6.45M10.54M102.13M95.31M124.66M267.56M170.51M669.11M1.19B2.56B1.02B493.91M510.90M
Total Debt--1.00M-4.84M6.72M-5.39M-141.50M44.36M203.59M41.87M8.82M-
Net Debt-628.69K-994.92K-5.45M-10.54M-97.28M-88.59M-124.66M-262.17M-170.51M-527.61M-1.15B-2.35B-966.53M-485.10M-

Cash Flow

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-482.90K1.03M6.30M16.47M45.02M58.86M46.50M53.67M22.49M359.68M1.13B4.01B392.50M-85.05M-70.05M
Investing Cash Flow-123.58K-582.99K-2.73M-25.80M21.33M-64.74M-19.06M-204.51M-97.27M-43.37M-685.12M-2.23B-1.37B-138.12M-
Financing Cash Flow549.00K-83.36K1.90M13.42M20.39M-2.82M8.64M293.73M-22.27M182.92M82.27M-432.79M-670.06M-313.17M-
Capital Expenditure123.58K582.99K2.73M4.24M1.18M40.27M45.52M47.48M31.94M28.28M103.57M313.38M109.97M184.77M90.89M
Free Cash Flow-606.48K449.59K3.56M12.24M43.84M18.59M979.44K6.19M-9.45M331.40M1.02B3.70B282.52M-269.81M-160.95M
Dividends Paid51.00K83.36K52.78K2.52M4.09M26.63M26.63M26.63M19.98M6.66M282.94M548.77M582.48M47.39M263.26M
FCF to OCF125.59%43.54%56.58%74.27%97.38%31.58%2.11%11.54%-42.03%92.14%90.81%92.19%71.98%317.25%229.75%
Dividend Paid to FCF-8.41%18.54%1.48%20.63%9.33%143.31%2719.31%430.02%-211.34%2.01%27.65%14.83%206.17%-17.56%-163.57%

Earnings

Report DateAug 27, 2018Oct 23, 2018Dec 31, 2018Apr 24, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 29, 2020Aug 24, 2020Oct 22, 2020Dec 31, 2020Apr 27, 2021Aug 11, 2021Oct 27, 2021Dec 31, 2021Apr 26, 2022Aug 24, 2022Oct 27, 2022Dec 31, 2022Apr 26, 2023Aug 30, 2023Oct 30, 2023Dec 31, 2023Apr 29, 2024Jun 30, 2024Oct 30, 2024Dec 31, 2024Apr 29, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026
EPS Estimate--------------------------------
EPS Actual0.360.110.060.120.120.02-0.020.011.431.120.542.461.573.001.829.018.596.941.592.420.160.14-0.300.140.150.07-0.03-0.020.070.00-0.14-0.00
Surprise--------------------------------
TimingPre-marketAfter-hours-Pre-market---After-hoursPre-marketAfter-hours-After-hoursAfter-hoursAfter-hours-Pre-marketPre-marketAfter-hours-Pre-marketAfter-hoursPre-market-Pre-market-Pre-market-Pre-market----

Key Statistics & Ratios

Market Cap3.56B
Enterprise Value-71.80M
Trailing P/E0.00
Forward P/E0.00
Price / Sales13.34
Price / Book0.67
EPS-0.23
Book Value25.48
Revenue (TTM)267.22M
Gross Profit (TTM)92.69M
EBITDA-161.20M
Profit Margin-19.02%
Operating Margin-43.69%
Return on Equity-1.83%
Return on Assets-2.20%
Shares Outstanding232.52M
Shares Float102.01M
Beta0.36
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20251×
1.20Jun 12, 2025
20242×
0.03Oct 17, 20240.12May 28, 2024
20231×
3.70Jun 6, 2023
20222×
1.01Sep 21, 20222.01Jun 21, 2022
20212×
0.68Sep 7, 20210.64Jul 20, 2021
20201×
0.03Jun 1, 2020
20191×
0.10May 24, 2019
20181×
0.13Sep 21, 2018

Stock Splits

  • Jun 6, 20231.49:1
  • Jun 21, 20221.49:1
  • Jul 20, 20211.4:1